Volozhin A I, Sazhina T G, Chergeshtov Iu I, Arion V Ia, Panin M G, Shipkova T P
Stomatologiia (Mosk). 1996;75(2):46-8.
Sixty-three patients with congenital and acquired defects and deformations of facial bones without concomitant diseases were examined. Twenty-eight of them were operated on; auto- and alloplasty was resorted to in 18 patients, and to 10 patients tactivin was administered after common protocols for immunocorrection before or after surgery. Immunologic and clinical studies showed that immunodeficiency states are the most probable causes of postoperative complications following repair surgery on the facial bones. Tactivin normalized the immunity parameters and prevented the development of postoperative complications.
对63例无伴发疾病的先天性和后天性面骨缺损及畸形患者进行了检查。其中28例接受了手术；18例采用了自体和异体成形术，10例在手术前或手术后按照常规免疫纠正方案给予了tactivin。免疫学和临床研究表明，免疫缺陷状态是面骨修复手术后术后并发症最可能的原因。Tactivin使免疫参数正常化，并预防了术后并发症的发生。
